Alterity Therapeutics Limited (ATHE)

NASDAQ: ATHE · IEX Real-Time Price · USD

1.810

+0.020 (1.12%)

At close: Jul 2, 2024, 3:57 PM

1.930

+0.120 (6.63%)

After-hours: Jul 2, 2024, 4:25 PM EDT

Alterity Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018 - 2000
Selling, General & Admin	5.06	5.51	6.94	3.45	4.31	Upgrade
Research & Development	13.48	15.11	12.64	10.45	13.31	Upgrade
Other Operating Expenses	0.03	0	0	0.04	0.13	Upgrade
Operating Expenses	18.57	20.63	19.58	13.94	17.75	Upgrade
Operating Income	-18.57	-20.63	-19.58	-13.94	-17.75	Upgrade
Other Expense / Income	-4.87	-7.85	-4.27	-0.48	-5.41	Upgrade
Pretax Income	-13.7	-12.78	-15.31	-13.46	-12.34	Upgrade
Income Tax	0.1	0.07	0	0	0	Upgrade
Net Income	-13.81	-12.85	-15.31	-13.46	-12.34	Upgrade
Shares Outstanding (Basic)	2,428	2,406	1,697	895	616	Upgrade
Shares Outstanding (Diluted)	2,428	2,406	1,697	895	616	Upgrade
Shares Change	0.91%	41.79%	89.62%	45.33%	15.34%	Upgrade
EPS (Basic)	-3.42	-3.18	-5.40	-9.00	-12.00	Upgrade
EPS (Diluted)	-3.42	-3.18	-5.40	-9.00	-12.00	Upgrade
Free Cash Flow	-20.04	-12.43	-17.34	-9.45	-13.96	Upgrade
Free Cash Flow Per Share	-4.95	-3.10	-6.13	-6.33	-13.60	Upgrade
EBITDA	-	-12.78	-15.31	-13.46	-12.34	Upgrade
EBIT	-13.7	-12.78	-15.31	-13.46	-12.34	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).